1 recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
Follow Gan Lijun: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I) Drug-coated balloon, Single antiplatelet therapy (SAPT), Dual antiplatelet therapy (DAPT) - Coronary Heart Disease (CHD) | Not applicable | Recruiting | Gan Lijun | 2170 | 2026-05-04 | 2026-08-17 |
Coronary Disease (1)
China (1)
PMID 15824203, PMID 16253582, PMID 17982182, PMID 1906692, PMID 21670242, PMID 22386286, PMID 27069105, PMID 27379610, PMID 28183511, PMID 29897428, PMID 29992264, PMID 30170854, PMID 30368735, PMID 30571511, PMID 31565793, PMID 31797532, PMID 32740442, PMID 33091360, PMID 33156965, PMID 36682076, PMID 36847902, PMID 38956941, PMID 39105679, PMID 39124787, PMID 39660933, PMID 40051028, PMID 40164448, PMID 40582348